(News 1st); The researchers at Melbourne University and the Monash University in Melbourne in collaboration, Australia have manufactured a blood thinner to be sprayed into the nose as a trial drug against COVID-19.

The newly manufactured drug, ‘Nasal Spray’ to obtain protection against COVID-19. 

However, this drug will not be introduced for commercial use until mid-2022.

Moreover, if the drug is used alongside vaccines, it could benefit as an additional immunity booster, stated Australian researchers.

Furthermore, they stated the spray could help both as early treatment and as a nasal mask to stop the virus from spreading from person to person.

Moreover, the researchers stated that it has been recommended to draw two puffs, three times a day to see if the drug works to prevent household transmission and infecting non-infected residents. If it proves to be effective, it can be globally distributed as an effective drug against COVID-19.

• Watch FACE THE NATION. Every Wednesday @ 9.30 pm on TV-1. Dialog TV Ch10. PEO TV Ch12
• Shi Yan 6: Ruhuna University steps away from joint research program
• Watch The People’s Platform. Every Tuesday and Friday @ 9.30 pm on TV-1. Dialog TV Ch10. PEO TV Ch12
• NEWSLINE. Asking questions you want answered. Every weekday 8.30 pm on TV-1, Dialog TV 10, PEO TV 12
• TOTT | How the X – Press Pearl will affect you for decades to come | Dharshani Lahandapura | 03rd of October 2023